Advertisement
Screener

NOMAD POWER SOLUTIONS, INC. (NMAD) Retained Earnings

2.8 / 5 stars · 68/120 Roast Me

NOMAD POWER SOLUTIONS, INC. Retained Earnings

NOMAD POWER SOLUTIONS, INC. (NMAD) had Retained Earnings of -$62.19 million as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent

us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14

  • 2026-06-30: Retained Earnings (Accumulated Deficit) -$62.19M.
  • 2026-03-31: Retained Earnings (Accumulated Deficit) -$60.00M.
  • 2025-12-31: Retained Earnings (Accumulated Deficit) -$58.08M.
  • 2025-09-30: Retained Earnings (Accumulated Deficit) -$55.53M.
Period endRetained Earnings (Accumulated Deficit)
2026-06-30-$62.19M
10-Q · filed 2026-08-14
2026-03-31-$60.00M
10-Q · filed 2026-05-14
2025-12-31-$58.08M
10-Q · filed 2026-08-14
2025-09-30-$55.53M
10-Q · filed 2025-11-12
2025-06-30-$53.55M
10-Q · filed 2025-08-07
2025-03-31-$52.78M
10-Q · filed 2025-05-12
2024-12-31-$52.07M
10-K · filed 2026-03-31
2024-09-30-$51.45M
10-Q · filed 2024-11-12
2024-06-30-$50.46M
10-Q · filed 2024-08-08
2024-03-31-$49.45M
10-Q · filed 2024-05-09
2023-12-31-$48.48M
10-K · filed 2025-03-24
2023-09-30-$47.45M
10-Q · filed 2023-11-09
2023-06-30-$46.43M
10-Q · filed 2023-08-09
2023-03-31-$44.76M
10-Q · filed 2023-05-10
2022-12-31-$43.39M
10-K · filed 2024-03-19
2022-09-30-$41.76M
10-Q · filed 2022-11-08
2022-06-30-$40.29M
10-Q · filed 2022-08-10
2022-03-31-$38.74M
10-Q · filed 2022-05-11
2021-12-31-$37.08M
10-K · filed 2023-03-29
2021-09-30-$35.05M
10-Q · filed 2021-11-10
2021-06-30-$33.81M
10-Q · filed 2021-08-10
2021-03-31-$32.08M
10-Q · filed 2021-05-12
2020-12-31-$30.35M
10-K · filed 2022-03-21
2020-09-30-$29.45M
10-Q · filed 2020-11-10
2020-06-30-$27.85M
10-Q · filed 2020-08-10
2020-03-31-$27.47M
10-Q · filed 2020-05-11
2019-12-31-$27.09M
10-K · filed 2021-03-26
2019-09-30-$26.77M
10-Q · filed 2019-11-08
2019-06-30-$25.69M
10-Q · filed 2019-08-06
2019-03-31-$25.08M
10-Q · filed 2019-05-09
2018-12-31-$24.65M
10-K · filed 2020-03-25
2018-09-30-$24.30M
10-Q · filed 2018-11-08
2018-06-30-$23.27M
10-Q · filed 2018-08-02
2018-03-31-$22.89M
10-Q · filed 2018-04-27
2017-12-31-$22.52M
10-K · filed 2019-03-25
2017-09-30-$22.08M
10-Q · filed 2017-11-09
2017-06-30-$21.62M
10-Q · filed 2017-08-04
2017-03-31-$21.33M
10-Q · filed 2017-05-10
2016-12-31-$20.71M
10-K · filed 2018-03-23
2016-09-30-$20.19M
10-Q · filed 2016-11-04
2016-06-30-$19.54M
10-Q · filed 2016-08-10
2016-03-31-$18.99M
10-Q · filed 2016-05-06
2015-12-31-$18.57M
10-K · filed 2017-03-29
2015-09-30-$17.96M
10-Q · filed 2015-11-10
2015-06-30-$17.18M
10-Q · filed 2015-08-07
2015-03-31-$16.68M
10-Q · filed 2015-05-13
2014-12-31-$15.72M
10-K · filed 2016-03-28
2014-09-30-$15.12M
10-Q · filed 2014-11-12
2014-06-30-$14.62M
10-Q · filed 2014-08-08
2013-12-31-$12.95M
10-K · filed 2015-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
TALPHERA, INC. (TLPH)United States$0.060B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Xilio Therapeutics, Inc. (XLO)United States$0.052B